NO20072192L - Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater - Google Patents

Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater

Info

Publication number
NO20072192L
NO20072192L NO20072192A NO20072192A NO20072192L NO 20072192 L NO20072192 L NO 20072192L NO 20072192 A NO20072192 A NO 20072192A NO 20072192 A NO20072192 A NO 20072192A NO 20072192 L NO20072192 L NO 20072192L
Authority
NO
Norway
Prior art keywords
preparation
intermediates
new product
azetidine derivatives
azetidin
Prior art date
Application number
NO20072192A
Other languages
English (en)
Norwegian (no)
Inventor
Michel Lavigne
Luc Grondard
Stephane Mutti
Jorg Rieke-Zapp
Joel Malpart
Veronique Crocq-Stuerga
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20072192L publication Critical patent/NO20072192L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20072192A 2004-10-14 2007-04-27 Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater NO20072192L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine
PCT/FR2005/002490 WO2006040465A2 (fr) 2004-10-14 2005-10-10 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
NO20072192L true NO20072192L (no) 2007-04-27

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20072192A NO20072192L (no) 2004-10-14 2007-04-27 Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater

Country Status (21)

Country Link
US (1) US7687493B2 (fr)
EP (1) EP1805167A2 (fr)
JP (1) JP2008516932A (fr)
KR (1) KR20070063544A (fr)
CN (1) CN101039931A (fr)
AR (1) AR051390A1 (fr)
AU (1) AU2005293454A1 (fr)
BR (1) BRPI0516507A (fr)
CA (1) CA2583992A1 (fr)
EA (1) EA011408B1 (fr)
EC (1) ECSP077332A (fr)
FR (1) FR2876688B1 (fr)
IL (1) IL181904A0 (fr)
MA (1) MA29513B1 (fr)
MX (1) MX2007003923A (fr)
NO (1) NO20072192L (fr)
SG (1) SG155193A1 (fr)
TN (1) TNSN07097A1 (fr)
TW (1) TW200630358A (fr)
WO (1) WO2006040465A2 (fr)
ZA (1) ZA200702528B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
JP4101053B2 (ja) * 2000-08-10 2008-06-11 田辺三菱製薬株式会社 プロリン誘導体及びその医薬用途
US7825109B2 (en) * 2003-08-29 2010-11-02 Ono Pharmaceutical Co., Ltd. Compound capable of binding S1P receptor and pharmaceutical use thereof

Also Published As

Publication number Publication date
IL181904A0 (en) 2007-07-04
TW200630358A (en) 2006-09-01
BRPI0516507A (pt) 2008-09-16
JP2008516932A (ja) 2008-05-22
WO2006040465A2 (fr) 2006-04-20
SG155193A1 (en) 2009-09-30
MA29513B1 (fr) 2008-06-02
WO2006040465A3 (fr) 2006-08-10
US20070270463A1 (en) 2007-11-22
US7687493B2 (en) 2010-03-30
FR2876688B1 (fr) 2007-03-16
AU2005293454A1 (en) 2006-04-20
EP1805167A2 (fr) 2007-07-11
EA011408B1 (ru) 2009-02-27
ECSP077332A (es) 2007-04-26
ZA200702528B (en) 2008-07-30
CN101039931A (zh) 2007-09-19
CA2583992A1 (fr) 2006-04-20
FR2876688A1 (fr) 2006-04-21
EA200700840A1 (ru) 2007-08-31
AR051390A1 (es) 2007-01-10
MX2007003923A (es) 2007-06-07
KR20070063544A (ko) 2007-06-19
TNSN07097A1 (fr) 2008-06-02

Similar Documents

Publication Publication Date Title
NO20076498L (no) Derivater av 4-(2-amino-1-hydroksyetyl)fenol som agonister av den betta2-adrenerge reseptoren
NO20082145L (no) Prolinamidderivater som natriumkanalmodulatorer
NO20050828L (no) lndol-3-svovelderivater
NO20060847L (no) Substituert 2-aminotetralin til behandling av depresjon
TW200624421A (en) Method for preparing n-phenylpyrazole-1-carboxamides
NO20060402L (no) 3-amino choman og 2-aminotetralinderivater
ATE543807T1 (de) Verstärker von glutamat-rezeptoren
NO20073366L (no) 1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose
MY136883A (en) 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
NZ798171A (en) Processes and intermediates for the preparation of (s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropane-2-yl)-1h-pyrazole-4-carboxamide
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
NO20054787L (no) Indenderivater som farmasotiske midler
DK1626720T3 (da) 4-(2-Phenylsulfanyl-phenyl)-piperidinderivater som serotonin-genoptagelseshæmmer
NO20070974L (no) Substituerte N-acyl-2-aminotiazoler
CY1112390T1 (el) Διαδικασια και ενδιαμεσα παρασκευης παραγωγων της ν-(1-βενζυδρυλ-αζετιδιν-3-υλ)-ν-φαινυλ-μεθυλσουλφοναμιδης
NO20072192L (no) Nytt produkt, fremgangsmate og mellomprodukter for fremstilling av azetidinderivater
TW200745039A (en) Isotopically substituted pantoprazole
HRP20030653B1 (en) Novel benzoylguanidine salt
DK1638948T3 (da) Diphenylurinstofderivater og deres anvendelse som chloridkanalblokkere
ATE442370T1 (de) Fungizide 6-phenyl-pyrazolopyrimidin-7-ylamine
SG145571A1 (en) Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
NO20064112L (no) Farmasoytiske doseringsformer og preparater
ZA200505531B (en) 4-(1-(Sulfonyl)-1H-indol-2-yl)-4-(hydroxy)-cyclohexa-2,5-dienone compounds and analogs thereof as thereapeutic agents
UY29166A1 (es) Nuevo producto, procedimiento e intermediarios de preparación de derivados de azetidina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application